We observed that the administration of the HE in the low dose of 0.5 mg/L determined statistically significant increases in the brain CAT activity, the statistical significance was obtained by reference to the enzymatic activity of CAT specific to the group treated with SCOP (p < 0.001). The gene discussed is CAT; the disease is hereditary elliptocytosis.